Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

September 2, 2016

Mechanism Found that May Explain BPH Development, Patient Resistance to Treatment

News

Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate, affects many older men, and it is associated with decreased quality of life and onset of lower urinary tract symptoms ... Read more

September 1, 2016

In BPH Patients Who Undergo HoLEP, Certain Risk Factors May Predict Urinary Incontinence

News

In recent years, several laser systems, such as holmium laser enucleation of the prostate (HoLEP), have been applied in the surgical management of benign prostatic hyperplasia (BPH). Researchers at Tama-Nambu ... Read more

August 31, 2016

Review Highlights Interactions Between BPH Medications and Consumption of Food, Alcohol

News

The appropriate management of benign prostatic hyperplasia (BPH) includes the counseling of patients regarding not only the interactions with different medications, but also between medications and food. Here, researchers reviewed ... Read more

August 29, 2016August 29, 2016

Serum Zinc Concentration Seen as Diagnostic Marker for BPH and Prostate Cancer

News

Zinc, an important element in human metabolism, is present in different concentrations in several organs. Importantly, zinc has been shown to modify prostatic androgen metabolism, and various studies have investigated the ... Read more

August 16, 2016

Conflicting Evidence in Cigarette Smoking, Benign Prostate Hyperplasia Risk

News

Cigarette smoking is a dangerous habit with harmful impacts associated with the development of several diseases but recent studies on the effects of smoking and benign prostatic hyperplasia (BPH) show ... Read more

August 15, 2016August 15, 2016

Version of Traditional Herbal Medicine Seen to Prevent BPH in Animal Study

News

A water extract version of Yongdamsagan-tang, a widely used traditional herbal treatment for inflammation and viral diseases, was seen to prevent the development benign prostatic hyperplasia (BPH) in rat models of the disorder, ... Read more

August 10, 2016

Specific Hormonal Receptors May Play Key Role in BPH Progression and Inhibition, Chinese Researchers Find

News

Researchers at China’s Third Military Medical University studied the expression of different hormonal receptors in benign prostatic hyperplasia (BPH) and in a normal prostate in both human tissue and an animal ... Read more

August 3, 2016

BPH Patients Respond Better to Combo Therapy of Detrol and Cardura, According to Study

News

Researchers assessed the efficacy and safety of a combination therapy of two different α-blockers, Cardura (doxazosin) and Flomax (tamsulosin), with Detrol (tolterodine), as evidence supports the superiority of this strategy over ... Read more

August 2, 2016August 2, 2016

Specific Laser Prostate Procedure Is Safe BPH Treatment in Elderly, Researchers Say

News

Holmium laser enucleation of the prostate (HoLEP) is an increasingly used safe and effective alternative for the management of benign prostatic hyperplasia (BPH). Researchers studied the outcomes of this treatment ... Read more

August 1, 2016

B-TURP for BPH in Larger Prostates is Preferred Treatment by Surgeons, According to Study from India

News

Researchers compared the outcomes of two surgical approaches to treat bladder obstruction due to benign prostatic hyperplasia (BPH). The findings reveal that, despite conflicting literature, bipolar transurethral resection of prostate (B-TURP) ... Read more